{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:13:44Z","timestamp":1786986824840,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.clgc.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T12:55:44Z","timestamp":1334235344000},"page":"174-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["A Randomized Trial Comparing Tamoxifen Therapy vs. Tamoxifen Prophylaxis in Bicalutamide-Induced Gynecomastia"],"prefix":"10.1016","volume":"10","author":[{"given":"Vincenzo","family":"Serretta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Morgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Nicolosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"De Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darwin","family":"Melloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Allegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ferra\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Gebbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2012.03.002_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1040-8428(00)00051-2","article-title":"Hormone therapy of prostate cancer: is there a role for antiandrogen monotherapy?","volume":"35","author":"Boccardo","year":"2000","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.clgc.2012.03.002_bib2","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0022-5347(05)67032-2","article-title":"Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup","volume":"164","author":"Iversen","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2012.03.002_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2005.06051.x","article-title":"Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer","volume":"97","author":"McLeod","year":"2006","journal-title":"BJU Int"},{"issue":"suppl 2","key":"10.1016\/j.clgc.2012.03.002_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000052339","article-title":"Quality of life issues relating to endocrine treatment options","volume":"36","author":"Iversen","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2012.03.002_bib5","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1097\/01.ju.0000181824.28382.5c","article-title":"Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy","volume":"174","author":"Di Lorenzo","year":"2005","journal-title":"J Urol"},{"issue":"suppl 4","key":"10.1016\/j.clgc.2012.03.002_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-5347(18)38306-X","article-title":"Once weekly tamoxifen in the prevention of gynaecomastia and breast pain secondary to bicalutamide therapy","volume":"171","author":"Eaton","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2012.03.002_bib7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.2005.12.013","article-title":"Evaluation of tamoxifen and anastrozole in the prevention of gynaecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer","volume":"23","author":"Boccardo","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2012.03.002_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.pcan.4500782","article-title":"Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole","volume":"8","author":"Saltzstein","year":"2005","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2012.03.002_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(05)70103-0","article-title":"Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial","volume":"6","author":"Perdon\u00e0","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2012.03.002_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0302-2838(03)00366-X","article-title":"Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer","volume":"44","author":"See","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2012.03.002_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.eururo.2004.12.003","article-title":"Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer","volume":"47","author":"Van Poppel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2012.03.002_bib12","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/01.ju.0000176461.75794.f8","article-title":"Incidence and management of gynecomastia in men treated for prostate cancer","volume":"174","author":"Dobs","year":"2005","journal-title":"J Urol"},{"issue":"suppl","key":"10.1016\/j.clgc.2012.03.002_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1569-9056(05)80320-3","article-title":"Development and validation of a new questionnaire to assess gynaecomastia and breast pain in patients receiving bicalutamide","volume":"4","author":"Van Poppel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2012.03.002_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2007.01.031","volume":"52","author":"Fradet","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2012.03.002_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eururo.2009.05.019","article-title":"An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients","volume":"57","author":"Bedognetti","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2012.03.002_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(19940701)74:1<74::AID-CNCR2820740113>3.0.CO;2-#","article-title":"Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients","volume":"74","author":"Anelli","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2012.03.002_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2007.01.063","article-title":"Bicalutamide-induced gynaecomastia: do we have the answer?","volume":"52","author":"Di Lorenzo","year":"2007","journal-title":"Eur Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767312000535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767312000535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:21:39Z","timestamp":1761564099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767312000535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1558767312000535"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2012.03.002","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized Trial Comparing Tamoxifen Therapy vs. Tamoxifen Prophylaxis in Bicalutamide-Induced Gynecomastia","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2012.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}